stock
MRNA · Moderna, Inc.
What Moderna, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live MRNA price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on MRNA.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 399,235,889 as of 2026-07-24 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -149.0%
- Net
- -141.4%
Returns
- ROE
- -46.6%
- ROA
- -28.7%
Health
- Current ratio
- 2.3x
- Debt/equity
- 0.1x
Deep value
- NCAV
- $1.61B
- NCAV per share
- $4.05
- Price/NCAV
- Locked
- NNWC
- -$2.32B
- NNWC per share
- -$5.82
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $145.00M | —Gross profit: unreported by this company. | -$815.00M | -$782.00M | 10-Q filed 2026-07-31 |
| 2026-03-31 | $389.00M | —Gross profit: unreported by this company. | -$1.39B | -$1.34B | 10-Q filed 2026-05-01 |
| 2025-12-31 | $678.00M | —Gross profit: unreported by this company. | -$857.00M | -$826.00M | 10-K filed 2026-02-20 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | $1.02B | —Gross profit: unreported by this company. | -$260.00M | -$200.00M | 10-Q filed 2025-11-06 |
| 2025-06-30 | $142.00M | —Gross profit: unreported by this company. | -$907.00M | -$825.00M | 10-Q filed 2026-07-31 |
| 2025-03-31 | $108.00M | —Gross profit: unreported by this company. | -$1.05B | -$971.00M | 10-Q filed 2026-05-01 |
| 2024-12-31 | $966.00M | —Gross profit: unreported by this company. | -$1.25B | -$1.12B | 10-K filed 2026-02-20 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | $1.86B | —Gross profit: unreported by this company. | -$70.00M | $13.00M | 10-Q filed 2025-11-06 |
- Assets
- $10.96B
- Equity
- $6.76B
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $1.94B | -$3.07B | -$2.82B | -$2.06B |
| 2024-12-31 | $3.24B | -$3.94B | -$3.56B | -$4.05B |
| 2023-12-31 | $6.85B | -$4.24B | -$4.71B | -$3.83B |
| 2022-12-31 | $19.26B | $9.42B | $8.36B | $4.58B |
| 2021-12-31 | $18.47B | $13.30B | $12.20B | $13.34B |
| 2020-12-31 | $803.00M | -$763.00M | -$747.00M | $1.96B |
| 2019-12-31 | $60.21M | -$546.00M | -$514.00M | -$491.00M |
| 2018-12-31 | $135.07M | -$413.27M | -$384.73M | -$436.63M |
| 2017-12-31 | $205.82M | -$269.36M | -$255.92M | -$389.88M |
| 2016-12-31 | $108.40M | -$223.77M | -$216.21M | $33.59M |
Company filings
events
Executive or director change, Regulation FD disclosure
Executive or director changeRegulation FD disclosureSep 308-KMaterial agreement, New debt, Unregistered share sale, Other event
Material agreementNew debtUnregistered share saleOther eventSep 18-KResults
ResultsJul 318-KExecutive or director change, Regulation FD disclosure
Executive or director changeRegulation FD disclosureJul 88-KBylaws or fiscal year change, Shareholder vote results
Bylaws or fiscal year changeShareholder vote resultsMay 118-KResults
ResultsMay 18-K
5% owners ()
Capital World Investors
Passive stake
FMR LLC
Stake update
BAILLIE GIFFORD & CO
Stake update
Vanguard Capital Management
Passive stake
The Vanguard Group
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Couldn’t load insider trades
This read is unavailable. Try it again without changing anything on the page.
Politician trades, last 90 days
Maria Elvira Salazar
House · FL27
SalePartial$1,001 to $15,000Wed Sep 9
Maria Elvira Salazar
House · FL27
Buy$1,001 to $15,000Wed Sep 9
Funds
- Baillie Gifford
Period Tue 30 Jun 2026
1.2%Trimmed - Point72
Calls · Period Tue 30 Jun 2026
0.0%Trimmed - Point72
Puts · Period Tue 30 Jun 2026
0.0%Added - Bridgewater Associates
Period Tue 30 Jun 2026
0.0%Trimmed
News
Stories that named MRNA, and the market events around them.
Sign in to see thisBoard
The MRNA board could not be loaded.
Retry the MRNA boardnakagai
Signals on MRNA come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the MRNA board